Lindsey Shapiro, PhD

Lindsey is a senior science writer for Bionews with a PhD in neuroscience from Emory University. There, she was awarded a predoctoral fellowship from the American Epilepsy Society to study the role of new therapeutic approaches for treatment of resistant forms of epilepsy. She also spent time as a postdoctoral researcher exploring the role of inflammation in epilepsy. With a passion for ensuring that science is accessible to all, Lindsey joined Bionews as a science writer in 2022.

Education

• PhD in neuroscience, Emory University, 2021
• B.S. in neuroscience, The University of New Hampshire, 2014

Published Works

• Cannabidiol Increases Seizure Resistance and Improves Behavior in an Scn8a Mouse Model. Frontiers in Pharmacology, 2022
• Allosteric modulation of the cannabinoid 2 receptor confers seizure resistance in mice. Neuropharmacology, 2021
• Nanoparticle encapsulated oxytocin increases resistance to induced seizures and restores social behavior in Scn1a-derived epilepsy. Neurobiology of disease, 2021
• Pathogenic in-Frame Variants in SCN8A: Expanding the Genetic Landscape of SCN8A-Associated Disease Frontiers in Pharmacology, 2021
• Reduced cannabinoid 2 receptor activity increases susceptibility to induced seizures in mice. Epilepsia, 2019

Professional Accomplishments

• Awarded a predoctoral fellowship from The American Epilepsy Society in 2019

At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.